Drug Patent Watch

FEBRUARY 13, 2025

The Unsung Heroes of Generic Drug Development: The Power of Partnerships As we navigate the complex landscape of pharmaceuticals, it's easy to overlook the crucial role that partnerships play in bringing affordable, life-saving medications to market. When it comes to developing generic drugs, partnerships can take many forms.

Drug Development 80

Drug Development Pharmaceutical Companies Pharmaceutical Companies 80

STAT

SEPTEMBER 9, 2024

To be clear, I’m not writing this to claim credit for discovery or development of GLP-1s or anything like that. Rather, I think the story offers valuable lessons on drug development for pharmaceutical companies, researchers, and the general public alike. Read the rest…

Drug Development 356

Drug Development Pharmaceutical Companies Pharmaceutical Companies 356

Drug Patent Watch

JANUARY 14, 2025

.”[2] This study not only addressed the ATA’s concerns but also highlighted the power of real-world evidence in generic drug development and regulation. Case Study 3: Modeling the Future of Generic Drugs Who says you need a crystal ball to predict the future?

Drug Development 86

Drug Development Labelling Pharmaceutical Companies Pharmaceutical Companies 86

STAT

AUGUST 19, 2024

. The company — or, at least, what existed at its founding in 2013 — hoped to pull data from images of healthy and diseased cells, and use that data to identify drugs gathering dust on pharmaceutical company shelves that could be repurposed as rare disease treatments. 

Medical Schools 362

Medical Schools Drug Development Pharmaceutical Companies Pharmaceutical Companies 362

Drug Patent Watch

DECEMBER 30, 2024

The regulatory environment in Japan for generic drug development is complex and has undergone significant changes in recent years. New Drug Application (NDA) : Needed for marketing approval of new drugs. Abbreviated New Drug Application (ANDA) : Required for marketing approval of generic drugs.

Drug Development 52

Drug Development Clinical Pharmacology Pharmaceutical Companies Pharmaceutical Companies 52

STAT

NOVEMBER 4, 2022

The legislation, known as the Pasteur Act, would encourage drug development by creating a subscription-style business model in which the U.S. The idea is to enable pharmaceutical companies to recover their costs and make an appropriate profit without having to sell large volumes of antibiotics.

Drug Development 297

Drug Development Pharmaceutical Companies Pharmaceutical Companies 297

Drug Patent Watch

OCTOBER 28, 2024

The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to streamline the drug development and manufacturing process. Here are the top 10 CDMO services you might not have known you needed… Source

Pharmaceutical Companies 109

Pharmaceutical Companies Pharmaceutical Companies Drug Development 109

STAT

SEPTEMBER 12, 2024

The BIOSECURE Act would prohibit many biotech and pharmaceutical companies from conducting certain research and development activities, including the manufacturing of drugs through named Chinese companies. BIOSECURE proponents argue that allowing the Chinese Communist Party access to U.S.

Pharmaceutical Companies 341

Pharmaceutical Companies Pharmaceutical Companies Drug Development 341

STAT

OCTOBER 17, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You

Drug Development 339

Drug Development Pharmaceutical Companies Pharmaceutical Companies 339

STAT

JULY 2, 2024

These medications don’t have to be so expensive, but all too often pharmaceutical companies use illegal tactics to block competition that could lower prices and encourage innovation. Americans are facing an affordability crisis at the hands of corporate titans. Read the rest…

Pharmaceutical Companies 363

Pharmaceutical Companies Pharmaceutical Companies Drug Development 363

STAT

SEPTEMBER 26, 2022

In an effort to sway the Food and Drug Administration not to withdraw accelerated approval of Makena, a drug developed to prevent preterm birth that does no such thing, a pharmaceutical company owned by a private equity company is making the specious argument that the drug should be kept on the market because it may — the emphasis is mine — (..)

Pharmaceutical Companies 263

Pharmaceutical Companies Pharmaceutical Companies Drug Development 263

STAT

MARCH 21, 2024

Early data regarding the use of GLP-1 medications like Ozempic and Wegovy to treat addiction is “very, very, exciting,” Nora Volkow, the director of the National Institute on Drug Abuse, said Thursday. drug crisis with urgency.

Pharmaceutical Companies 361

Pharmaceutical Companies Pharmaceutical Companies Drug Development 361

STAT

OCTOBER 4, 2022

The press release issued by pharmaceutical companies Eisai and Biogen on Sept. Years and years of failed Alzheimer’s trials created, and then fortified , doubts about whether drugs that attacked amyloid, a brain protein linked to Alzheimer’s disease, were a valid approach to its treatment.

Pharmaceutical Companies 328

Pharmaceutical Companies Pharmaceutical Companies Drug Development 328

European Pharmaceutical Review

JUNE 27, 2022

DRUG DEVELOPMENT based on targeted protein degradation (TPD) has progressed rapidly since the publication in 2015 of three landmark papers 1-3 that highlighted important early-stage breakthroughs with drug-like molecules in this area of research.

Drug Development 105

Drug Development Pharmaceutical Companies Pharmaceutical Companies 105

STAT

OCTOBER 5, 2023

Some scientists are trying to calculate those footprints, as part of a growing effort to understand biotech and pharmaceutical companies’ contributions to climate change. What if that information also included your medicine’s carbon footprint?

Pharmaceutical Companies 341

Pharmaceutical Companies Pharmaceutical Companies Drug Development 341

STAT

MAY 22, 2024

A 2024 analysis of drugs included in this program showed they had 23% shorter clinical development timelines than those that were not part of the program, with no negative effects on their safety profiles.

Pharmaceutical Companies 302

Pharmaceutical Companies Pharmaceutical Companies Drug Development 302

STAT

APRIL 18, 2024

A leading animal rights group has asked securities regulators to investigate Charles River Laboratories for allegedly misleading investors about its sales and purchases of long-tailed macaques, which are widely used in clinical research by pharmaceutical companies and universities, among others.

Labelling 351

Labelling Pharmaceutical Companies Pharmaceutical Companies Drug Development 351

STAT

FEBRUARY 29, 2024

CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols. Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services.

Pharmaceutical Companies 353

Pharmaceutical Companies Pharmaceutical Companies Drug Development 353

European Pharmaceutical Review

SEPTEMBER 12, 2023

Initial data from the CPHI Annual Report 2023, which provides insight from 250 global pharmaceutical companies, reveals that AI (artificial intelligence) is expected to transform every area of the industry, from drug discovery through to drug development , within the next 24-months. Attending CPHI Barcelona 2023?

Drug Development 105

Drug Development Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

SEPTEMBER 22, 2022

Rare disease drug development poses unique challenges that can be overcome by using real-world evidence (RWE). These assessments often need to involve comparisons against multiple alternative therapies that would be impractical in the context of a clinical drug development. Regulatory and payer guidance.

Drug Development 122

Drug Development Pharmaceutical Companies Pharmaceutical Companies Documentation 122

STAT

OCTOBER 15, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. 

Pharmaceutical Companies 277

Pharmaceutical Companies Pharmaceutical Companies Drug Development 277

Express Pharma

MARCH 2, 2025

Continued strategic focus on North America: US market accounts for anywhere between 30 per cent to 60 per cent of annual revenues for Leading Pharmaceutical companies in India. Companies will continue to acquire leadership capabilities with focus on these markets.

Biosimilars 99

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 99

Drug Patent Watch

DECEMBER 10, 2024

They can help ensure that these submissions are complete, accurate, and timely, which is critical for advancing drug development programs. They can help ensure that the commercial pharmaceutical manufacturing process is designed to meet regulatory requirements and offer insight into the most effective manufacturing strategies.

Documentation 98

Documentation Drug Development Pharmaceutical Manufacturing Pharmaceutical Companies 98

STAT

JULY 12, 2023

These medicines, colloquially called “n of 1” therapies, are often made to treat debilitating genetic conditions that are too rare to garner interest from pharmaceutical companies. Read the rest…

Pharmaceutical Companies 246

Pharmaceutical Companies Pharmaceutical Companies Drug Development 246

STAT

JANUARY 19, 2023

In a stunning rebuke, the Food and Drug Administration accused a drugmaker of a “cascade of failures” for a litany of quality-control problems at a manufacturing plant, the latest instance in which the regulator has castigated an Indian pharmaceutical company for such lapses.

Documentation 246

Documentation Pharmaceutical Companies Pharmaceutical Companies Drug Development 246

STAT

OCTOBER 3, 2022

Food and Drug Administration established in 1982 in an effort to get medicines for hard-to-treat diseases to patients sooner than they might under the usual pathways to the marketplace. As a condition of approval, a pharmaceutical company must confirm the effectiveness of its medicine through one or more clinical trials by a certain date.

Pharmaceutical Companies 246

Pharmaceutical Companies Pharmaceutical Companies Drug Development 246

STAT

MARCH 7, 2023

But he also said he saw it as an example of a drug company filling the void left by health systems that aren’t teaching doctors and trainees how to use new medicines. Continue to STAT+ to read the full story…

Medical Schools 246

Medical Schools Pharmaceutical Companies Pharmaceutical Companies Drug Development 246

STAT

NOVEMBER 15, 2022

For the first time, many of the world’s largest pharmaceutical companies are taking concrete steps to widen access to their medicines in low and middle-income countries, but the poorest countries continue to be disproportionately overlooked, according to a new analysis.

Pharmaceutical Companies 246

Pharmaceutical Companies Pharmaceutical Companies Drug Development 246

pharmaphorum

DECEMBER 21, 2021

During the course of the webinar, Keefer explained how specialty sites, with deep knowledge on one or certain groups of Rare Diseases, are crucial for further progress in drug development to progress the number of treatments available to Rare Disease patients and to provide support to those individuals.

Drug Development 98

Drug Development Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

Express Pharma

APRIL 8, 2025

To address growing demand from the pharmaceutical industry, Asahi Kasei has launched a new division, Asahi Kasei Life Science, effective from 1 April 2025. The new structure is designed to unify its bioprocess businesses and streamline services offered to pharmaceutical partners across drug development and manufacturing.

Pharmaceutical Manufacturing 76

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies Drug Development 76

Drug Patent Watch

DECEMBER 9, 2024

This approach has led to the discovery of numerous potential drug candidates. From Lab to Market: The Long Road of Drug Development Once a promising compound is identified, it enters the long and costly process of drug development. Q: How long does a drug patent last?

Compounding 97

Compounding Drug Development Documentation Pharmaceutical Companies 97

STAT

DECEMBER 13, 2024

This isn’t just a drug approval, but a major strategic shift. For more than 30 years, Ionis developed all of its medicines in partnership with large pharmaceutical companies. Peak sales could reach $2 billion in 2035, according to Wolfe Research, a sell-side research firm. This time, it is standing alone.

Pharmaceutical Companies 246

Pharmaceutical Companies Pharmaceutical Companies Drug Development 246

Express Pharma

DECEMBER 30, 2024

Universities serve as the foundational training ground for the next generation of pharmaceutical professionals. They offer various programs, from undergraduate degrees in pharmaceutical sciences to specialised graduate courses focusing on drug development, regulatory affairs, and market access.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Drug Development 105

Express Pharma

JULY 8, 2024

Shanghai Fosun Pharmaceutical to acquire the remaining stake in Shanghai Henlius Biotech, a biopharmaceutical company, for a consideration of approximately $692.5 million; NewGenIvf Group, to acquire COVIRIX Medical, a clinical-stage pharmaceutical company developing novel antiviral therapies for $617.3

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Drug Development 105

Express Pharma

MARCH 16, 2025

In India, pharmaceutical companies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques. First, advanced research and development (R&D) and biologics will be critical. This transition will require substantial investments in several key areas.

Biosimilars 110

Biosimilars Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies 110

Drug Patent Watch

DECEMBER 12, 2024

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Drug Development 96

European Pharmaceutical Review

NOVEMBER 14, 2023

Outsourcing regulatory activities in pharma Here, EPR’s Editor explores some key considerations, approaches and strategies for pharmaceutical companies looking to outsource regulatory activities.

Drug Development 98

Drug Development Pharmaceutical Companies Pharmaceutical Companies 98